TRS vs. JNJ

Last updated Apr 1, 2026

Compare and contrast key facts about TriMas Corporation (TRS) and Johnson & Johnson (JNJ).

Performance

TRS vs. JNJ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in TriMas Corporation (TRS) and Johnson & Johnson (JNJ). The values are adjusted to include any dividend payments, if applicable.

TRS vs. JNJ - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
TRS TriMas Corporation	1.49%	45.02%	-2.29%	-8.13%	-24.60%	16.97%	0.83%	15.10%	2.02%	13.83%
JNJ Johnson & Johnson	18.74%	47.48%	-4.81%	-8.58%	5.97%	11.44%	10.82%	16.22%	-5.13%	24.43%

Fundamentals

Market Cap TRS : $1.44B JNJ : $596.19B
EPS TRS : $2.01K JNJ : $11.04
PE Ratio TRS : 0.02 JNJ : 22.15
PEG Ratio TRS : 0.00 JNJ : 0.74
PS Ratio TRS : 0.00 JNJ : 6.30
PB Ratio TRS : 0.00 JNJ : 7.31
Total Revenue (TTM) TRS : $645.72B JNJ : $94.19B
Gross Profit (TTM) TRS : $138.16B JNJ : $68.56B
EBITDA (TTM) TRS : $30.07B JNJ : $39.85B

Returns By Period

In the year-to-date period, TRS achieves a 1.49% return, which is significantly lower than JNJ's 18.74% return. Over the past 10 years, TRS has underperformed JNJ with an annualized return of 7.56%, while JNJ has yielded a comparatively higher 11.41% annualized return.

TRS

• 1D: 1.10%
• 1M: -8.03%
• YTD: 1.49%
• 6M: -6.78%
• 1Y: 54.17%
• 3Y*: 9.52%
• 5Y*: 3.84%
• 10Y*: 7.56%

JNJ

• 1D: 0.80%
• 1M: -1.61%
• YTD: 18.74%
• 6M: 33.37%
• 1Y: 51.50%
• 3Y*: 19.92%
• 5Y*: 11.57%
• 10Y*: 11.41%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

TRS vs. JNJ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TRS

TRS Risk / Return Rank: 83
TRS Sharpe Ratio Rank: 86
TRS Sortino Ratio Rank: 85
TRS Omega Ratio Rank: 81
TRS Calmar Ratio Rank: 81
TRS Martin Ratio Rank: 80

JNJ

JNJ Risk / Return Rank: 94
JNJ Sharpe Ratio Rank: 96
JNJ Sortino Ratio Rank: 95
JNJ Omega Ratio Rank: 96
JNJ Calmar Ratio Rank: 93
JNJ Martin Ratio Rank: 93

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TRS vs. JNJ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for TriMas Corporation (TRS) and Johnson & Johnson (JNJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	TRS	JNJ	Difference
Sharpe ratio Return per unit of total volatility	1.62	2.71	-1.09
Sortino ratio Return per unit of downside risk	2.40	3.40	-1.00
Omega ratio Gain probability vs. loss probability	1.30	1.52	-0.22
Calmar ratio Return relative to maximum drawdown	2.47	4.55	-2.09
Martin ratio Return relative to average drawdown	5.87	13.23	-7.36
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

TRS vs. JNJ - Sharpe Ratio Comparison

The current TRS Sharpe Ratio is 1.62, which is lower than the JNJ Sharpe Ratio of 2.71. The chart below compares the historical Sharpe Ratios of TRS and JNJ, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	TRS	JNJ	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.62	2.71	-1.09
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.13	0.70	-0.57
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.24	0.62	-0.38
Sharpe Ratio (All Time) Calculated using the full available price history	0.16	0.54	-0.38

Correlation

The correlation between TRS and JNJ is 0.25, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

TRS vs. JNJ - Dividend Comparison

TRS's dividend yield for the trailing twelve months is around 0.45%, less than JNJ's 2.13% yield.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
TRS TriMas Corporation	0.45%	0.45%	0.65%	0.63%	0.58%	0.11%	0.00%	0.00%	0.00%	0.00%	0.00%	32.28%
JNJ Johnson & Johnson	2.13%	2.48%	3.40%	3.00%	2.52%	2.45%	2.53%	2.57%	2.74%	2.38%	2.73%	2.87%

Drawdowns

TRS vs. JNJ - Drawdown Comparison

The maximum TRS drawdown since its inception was -93.99%, which is greater than JNJ's maximum drawdown of -50.67%. Use the drawdown chart below to compare losses from any high point for TRS and JNJ.

Drawdown Indicators

	TRS	JNJ	Difference
Max Drawdown Largest peak-to-trough decline	-93.99%	-50.67%	-43.32%
Max Drawdown (1Y) Largest decline over 1 year	-22.24%	-8.42%	-13.82%
Max Drawdown (5Y) Largest decline over 5 years	-47.21%	-18.41%	-28.80%
Max Drawdown (10Y) Largest decline over 10 years	-47.21%	-27.37%	-19.84%
Current Drawdown Current decline from peak	-9.99%	-1.66%	-8.33%
Average Drawdown Average peak-to-trough decline	-27.60%	-11.90%	-15.70%
Ulcer Index Depth and duration of drawdowns from previous peaks	9.34%	4.04%	+5.30%

Volatility

TRS vs. JNJ - Volatility Comparison

TriMas Corporation (TRS) has a higher volatility of 11.33% compared to Johnson & Johnson (JNJ) at 4.48%. This indicates that TRS's price experiences larger fluctuations and is considered to be riskier than JNJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	TRS	JNJ	Difference
Volatility (1M) Calculated over the trailing 1-month period	11.33%	4.48%	+6.85%
Volatility (6M) Calculated over the trailing 6-month period	21.19%	11.09%	+10.10%
Volatility (1Y) Calculated over the trailing 1-year period	33.68%	19.14%	+14.54%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	30.61%	16.68%	+13.93%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	31.47%	18.33%	+13.14%

Financials

TRS vs. JNJ - Profitability Comparison

The chart below illustrates the profitability comparison between TriMas Corporation and Johnson & Johnson over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

TRS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, TriMas Corporation reported a gross profit of 137.98B and revenue of 644.93B. Therefore, the gross margin over that period was 21.4%.

JNJ - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Johnson & Johnson reported a gross profit of 21.22B and revenue of 24.56B. Therefore, the gross margin over that period was 86.4%.

TRS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, TriMas Corporation reported an operating income of 29.94B and revenue of 644.93B, resulting in an operating margin of 4.6%.

JNJ - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Johnson & Johnson reported an operating income of 5.39B and revenue of 24.56B, resulting in an operating margin of 22.0%.

TRS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, TriMas Corporation reported a net income of 81.70B and revenue of 644.93B, resulting in a net margin of 12.7%.

JNJ - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Johnson & Johnson reported a net income of 5.12B and revenue of 24.56B, resulting in a net margin of 20.8%.